drugset / Trial / NCT00192361

Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)

NCT00192361

Phase 3 Completed 200 enrolled MedImmune LLC
RandomizedParallel-groupDouble-blindPrevention

Summary

To assess whether CAIV-T was transmitted from vaccinated children to their unvaccinated contacts in a day care setting; and if so, to estimate the rate of transmission.

Timeline

Start
1999-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject FluMist Vaccine

Indications